Get complete Patent Opposition Report for Ucb Biopharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Ucb Biopharma

Explore patent oppositions filed by Ucb Biopharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2784084Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECHApr 23, 2020
EP2531218Immunoglobulin PreparationCSL BEHRINGSep 11, 2019
EP2282758Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related DisordersBIOARCTICAug 21, 2019
EP2144613Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MABDec 21, 2018
EP2606142Method For Inactivating Proteases By Ph Change In A Liquid Obtained From A Cell CultureBOEHRINGER INGELHEIMNov 28, 2018
EP2586788Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 29, 2018
EP2794652Rapid Method For Cloning And Expression Of Cognate Antibody Variable Region Gene SegmentsFHOFFMANN LA ROCHEAug 15, 2018

Explore Ucb Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3630946Mar 27, 2024Cell Culture Methods4
EP3717631Aug 30, 2023Cell Culture Methods2
EP3311168May 10, 2023Novel Tnf Structure For Use In Therapy2
EP2515887Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine4
EP2922533Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2